The question:

Can a vertebrate regenerate an entire lymphoid organ from no detectable remnant? The team asked whether axolotls (Ambystoma mexicanum) can re-create a complete, working thymus after complete thymectomy.

In most vertebrates the thymus, while partially regenerative, relies on pre-existing thymic remnants or progenitors and undergoes age-related involution; complete organ-level de novo regeneration had not been documented.

"We were stunned to see a complete thymus reappear and resume Tcell production — it rewrites what we thought was possible in vertebrate organ regeneration."

Why this was hard to prove:

Demonstrating true de novo organogenesis required exceptionally careful surgery and validation that no thymic tissue remained, highresolution timecourse imaging, singlecell maps to show all cell types reappear as well as how and when, functional assays to prove new T cells are produced and migrate, and loss-of-function tests to uncover the molecular drivers — all stitched together across years of work.

What they found (the big science):

Upon complete extraction of their thymus, the animals grew it back within 35 days. ‘The regenerating thymus isn’t just structural — it makes migratory, functional T cells that travel through the body‘: Regenerated thymic nodules match the original, intact ones in shape, cell-type diversity and gene programs. Importantly, they are functional: they recruit host hematopoietic progenitors to produce migratory T cells. Indeed, functional transplantation assays showed regenerated thymic nodules can recruit host hematopoietic progenitors and sustain host-derived thymopoiesis long-term.

The team leveraged single cell RNA sequencing to map the stages oif thymus reconstitution, assess the reappearance of its diverse cell populations and identify molecular drivers of the process. Foxn1 — a master regulator of thymus development — remains essential for thymic size and full T-cell output but is surprisingly not required to initiate the first rudiment of the regenerating thymus. Instead, BMP (a player previously known to influence mammalian thymus homeostasis) and a less understood pathway, Midkine (MDK) are required for de novo thymus regeneration. In particular, an injuryactivated burst of MDK is critical early on: blocking MDK sharply reduces regeneration, while other traditional pathways such as WNT were not required in this context. 

Why it matters (implications):

Conceptually, this is the first example of de novo regeneration of a complex lymphoid organ in a vertebrate, forcing a rethink of organlevel regenerative competence. It is a true biology milestone.

Practically, MDK and BMP become immediate, testable leads for therapies aimed at restoring thymic tissue after surgery or agerelated involution. If mammalian TECs or progenitors can be coaxed by similar signals, there may be routes to rebuild or boost thymic function — a major goal for improving immunity in surgery patients, immunedeficient individuals and older adults.

"If we can learn to safely recapitulate parts of this program in humans, it could improve immune recovery after surgery, in immune deficiencies, or during aging."

Regeneration biology: Provides a rare case of organlevel de novo regeneration, expanding what regenerative programs can achieve in vertebrates.

Immunology: It provides the first example of whole-organ level regeneration of the immune system among vertebrates and offers a comparative model of thymic epithelial cell (TEC) ontogeny, thymopoiesis and stromal signalling — with MDK emerging as a previously underappreciated actor. 

Translational medicine: MDK/BMP become candidate targets for preclinical work aimed at thymus repair after thymectomy or for age-associated immune decline.

Axolotls can rebuild a complete, working thymus from scratch after its removal — and the study identifies key molecular signals (including midkine) that drive this remarkable regrowth, offering new ideas for therapies to restore immune function in people who lack a healthy thymus.

Understanding the molecules and cell behaviours that allow axolotls to regrow a thymus could point to drug or cell-based approaches to help patients (e.g., children after surgery, people with thymic damage or age-related immune decline) recover or rebuild thymic function.

This research opens up important research avenues which the Yun lab has begun to pursue in CIMR. This includes unraveling the cellular nature of the de novo thymus progenitors, understanding how organ position, size and number is determined, determine how this remarkable regenerative capacity impacts on thymus involution, and test the impact of MDK/BMP modulation in thymus regeneration and resilience in other systems including mammals.

The project is a joint effort between the Yun lab (CIMR, CRTD) and the Maehr lab (Program in Molecular Medicine, University of Massachusetts Medical School). It merged expertise in axolotl regeneration, transgenesis, single-cell genomics, thymus biology, transplantation assays and computational cell–cell communication analyses.

It is the first report of regeneration of a whole, complex organ in a vertebrate, a highly significant finding.